- Previous Close
2,790.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 3,935.00 - Volume
0 - Avg. Volume
1,785,568 - Market Cap (intraday)
110.102B - Beta (5Y Monthly) -0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, and immunohistochemistry services. Noul Co.,Ltd. was founded in 2015 and is headquartered in Yongin-si, South Korea.
www.noul.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 376930.KQ
View MorePerformance Overview: 376930.KQ
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 376930.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 376930.KQ
View MoreValuation Measures
Market Cap
103.08B
Enterprise Value
93.85B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
64.38
Price/Book (mrq)
5.11
Enterprise Value/Revenue
58.60
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.51%
Return on Equity (ttm)
-71.15%
Revenue (ttm)
1.6B
Net Income Avi to Common (ttm)
-22.47B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
20.94B
Total Debt/Equity (mrq)
58.08%
Levered Free Cash Flow (ttm)
-14.12B